HOXC11–SRC-1 regulation of S100beta in cutaneous melanoma: new targets for the kinase inhibitor dasatinib

BACKGROUND: Cutaneous melanoma is an aggressive disease. S100beta is an established biomarker of disease progression; however, the mechanism of its regulation in melanoma is undefined. METHODS: Expression of HOXC11 and SRC-1 was examined by immunohistochemistry and immunofluorescence. Molecular and...

Descripción completa

Detalles Bibliográficos
Autores principales: deBlacam, C, Byrne, C, Hughes, E, McIlroy, M, Bane, F, Hill, A D K, Young, L S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137411/
https://www.ncbi.nlm.nih.gov/pubmed/21654685
http://dx.doi.org/10.1038/bjc.2011.193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137411/
https://www.ncbi.nlm.nih.gov/pubmed/21654685
http://dx.doi.org/10.1038/bjc.2011.193

Ejemplares similares